跳至主要内容
临床试验/NCT01982266
NCT01982266终止不适用

A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip

Biomimedica, Inc1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2013年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
1
主要终点
Adverse events

研究概览

简要总结

This is a prospective, multicenter, single arm feasibility study of the safety and performance of the GRADION™ Hip Total Cartilage Replacement (TCR)™ in patients who require cartilage replacement.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Primary hip surgery for Noninflammatory Degenerative Joint Disease (NIDJD) such as osteo/degenerative arthritis, and is indicated for cartilage replacement
  • •Skeletally mature or at least 18 years of age and has normal anatomy
  • •Patient signs the Informed Consent form
  • •Failed medical management
  • •There will be size limitations on patients also - available size range is 46mm-54mm.

排除标准

  • •Allergic to polyether urethane, sodium polyacrylate, bone cement or any of its components
  • •Previous fusion, acute femoral neck fracture and/or above knee amputation
  • •Revision of any previous hip procedure
  • •Slipped capital femoral epiphysis (SCFE)
  • •Rheumatoid arthritis

研究组 & 干预措施

GRADION™ Hip Total Cartilage Replacement (TCR)™

Experimental

干预措施: GRADION™ Hip Total Cartilage Replacement (TCR)™ (Device)

结局指标

主要结局

Adverse events

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验